首页|血培养大肠埃希菌的耐药特点、毒力基因分布及种系分型

血培养大肠埃希菌的耐药特点、毒力基因分布及种系分型

扫码查看
目的 检测并分析血培养大肠埃希菌的耐药特点、种系分型和毒力基因分布.方法 收集我院2019 年1 月1 日至2020年 12 月 13 日连续且非重复血培养大肠埃希菌.采用微量肉汤法测定大肠埃希菌对 17 种抗菌药物的敏感性;水煮法提取细菌基因组DNA,采用PCR法检测arpA、chuA、yjaA、TspE4C2、ArpAgpE和trpAgpC基因以确定细菌的种系分型;采用多重PCR法检测毒力基因iutA、fimH、fyuA、kpsMTⅡ、cnf1、cvac、hlyA、traT、kpsMTⅢ和PAI;使用卡方检验分析种系分型之间的耐药率及毒力基因分布差异.结果 270 株血培养大肠埃希菌对头孢曲松、复方新诺明、氨苄西林、氨苄西林/舒巴坦、头孢唑林和环丙沙星的耐药率较高,均大于 50.0%;对亚胺培南、厄他培南、阿米卡星和哌拉西林/他唑巴坦的敏感性较高,耐药率均低于5.0%.在种系分型方面,最常见的型别是B2 型和D型,分别占总数的 38.0%和 16.2%,而E型和隐分支Ⅰ型占比<1.0%,较为少见.毒力基因分析发现,fimH和fyuA基因的分布率最高,均在 99.0%以上,而kpsMT Ⅲ、hlyA和cvaC 3 种基因的分布率较低,均低于20.0%.卡方检验显示,毒力基因iutA、fimH、fyuA、kpsMTⅡ、cnf1、PAI在B2 型的分布显著高于非B2 型(P<0.05),且B2 型携带的iutA、fyuA、kpsMTⅡ、cnf1、PAI基因显著高于D型(P<0.05).结论 在治疗引起血流感染的大肠埃希菌时,应慎用头孢曲松、复方新诺明、氨苄西林、氨苄西林/舒巴坦、头孢唑林和环丙沙星等药物.血流感染的大肠埃希菌为B2 型时,应同时进行中段尿培养以确认感染源并监测治疗的成功率.
Drug resistance characteristics,virulence gene distribution,and phylogenetic typing of Escherichia coli in blood culture
Objective To detect and analyze the drug resistance characteristics,phylogenetic typing,and virulence gene distribution of Escherichia coli(E.coli)in blood culture.Methods The strains of E.coli isolated from consecutive non-repetitive blood cultures in our hospital from January 1,2019 to December 13,2020 were collected.The sensitivity of E.coli to 17 antibiotics was determined u-sing the micro-broth method.The bacterial genomic DNA was extracted using the boiling method,and then the arpA,chuA,yjaA,TspE4C2,ArpAgpE and trpAgpC genes were detected by PCR to determine the bacterial phylogroup.The virulence genes,including iutA,fimH,fyuA,kpsMT Ⅱ,cnf1,cvac,hlyA,traT,kpsMT Ⅲ,and PAI,were detected using the multiplex PCR.The differences in drug resistance and virulence gene distribution among different phylogroups were analyzed by the Chi-square test.Results 270 strains of E.coli in blood culture showed high resistance rates to ceftriaxone,compound sulfamethoxazole,ampicillin,ampicillin sulbactam,cefazolin,and ciprofloxacin,all exceeding 50.0%.They had good susceptibility to imipenem,ertapenem,amikacin,and piperacillin tazobactam,with resistance rates all below 5.0%.The most common phylogroups were types B2 and D,accounting for 38.0%and 16.2%,respectively,while type E and hidden branch type I were relatively rare,accounting for less than 1.0%.The virulence gene analysis revealed that the distribution rates of fimH and fyuA genes were the highest,both above 99.0%.The distribution rates of kpsMT Ⅲ,hlyA,and cvaC genes were relatively low,all below 20.0%.The Chi-square test showed that the distribution rates of viru-lence genes such as iutA,fimH,fyuA,kpsMT Ⅱ,cnf1,and PAI in the B2 group were significantly higher than those in the non-B2 group(P<0.05).The distribution rates of iutA,fyuA,kpsMT Ⅱ,cnf1,and PAI genes in the B2 group were significantly higher than those in the D group(P<0.05).Conclusion When treating bloodstream infections caused by E.coli,caution should be exercised in the use of drugs such as ceftriaxone,compound sulfamethoxazole,ampicillin,ampicillin sulbactam,cefazolin,and ciprofloxacin.When bloodstream infections are caused by phylogroup B2 E.coli,middle-stream urine culture should be performed simultaneously to confirm the source of infection and monitor the success rate of treatment.

Escherichia colidrug resistancevirulence genephylogenetic typing

马小轩、翟俊斌、曹小利、张燕、郑洁、张之烽、沈瀚

展开 >

南京大学附属鼓楼医院检验科,南京 210008

大肠埃希菌 耐药 毒力基因 种系分型

国家自然科学基金南京市卫生青年人才培养工程项目

81902124QRX17059

2024

临床检验杂志
江苏省医学会

临床检验杂志

CSTPCD
影响因子:0.746
ISSN:1001-764X
年,卷(期):2024.42(5)
  • 17